Archived 13: Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine in adolescents 12 to 18 years of age [2021-05-18]

Resumen documental de ASEM

Official National Advisory Committee on Immunization document (2021) on “Archived 13: Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine in adolescents 12 to 18 years of age [2021-05-18]”. NACI recommendation, background, methods, summary of evidence and rationale for the recommendation and research priorities.

Este resumen facilita la identificación del documento. Para consultar recomendaciones clínicas, consulte siempre la versión oficial vigente y su fecha de actualización.